# Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study

> **NCT00885495** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 17 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** darunavir, ritonavir, rosuvastatin
- **DRUG:** rosuvastatin, darunavir, ritonavir

## Key facts

- **NCT ID:** NCT00885495
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-04
- **Final completion:** 2010-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00885495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00885495, "Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00885495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*